X-78754873-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001278000.3(LPAR4):c.4G>A(p.Gly2Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,189,279 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001278000.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPAR4 | ENST00000614823.5 | c.4G>A | p.Gly2Ser | missense_variant | 5/5 | 4 | NM_001278000.3 | ENSP00000478261.1 | ||
LPAR4 | ENST00000435339.3 | c.4G>A | p.Gly2Ser | missense_variant | 2/2 | 1 | ENSP00000408205.2 | |||
LPAR4 | ENST00000514744.5 | c.4G>A | p.Gly2Ser | missense_variant | 4/4 | 4 | ENSP00000476460.1 |
Frequencies
GnomAD3 genomes AF: 0.0000360 AC: 4AN: 111186Hom.: 0 Cov.: 23 AF XY: 0.0000597 AC XY: 2AN XY: 33478
GnomAD3 exomes AF: 0.0000311 AC: 5AN: 160530Hom.: 0 AF XY: 0.0000196 AC XY: 1AN XY: 50980
GnomAD4 exome AF: 0.0000204 AC: 22AN: 1078093Hom.: 0 Cov.: 29 AF XY: 0.0000114 AC XY: 4AN XY: 350467
GnomAD4 genome AF: 0.0000360 AC: 4AN: 111186Hom.: 0 Cov.: 23 AF XY: 0.0000597 AC XY: 2AN XY: 33478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2024 | The c.4G>A (p.G2S) alteration is located in exon 2 (coding exon 1) of the LPAR4 gene. This alteration results from a G to A substitution at nucleotide position 4, causing the glycine (G) at amino acid position 2 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at